AKT1 and prostate cancer: Abnormally expressed NCAPD3 in prostate cancer caused STAT3 to be highly expressed and bound to the promoters of JAK2 and EZH2 to promote their transcription, increasing the level of AKT phosphorylation, and accelerating tumor development.